Q1 2022 Holdings
Filed 2022-05-13 | 8 holdings | $699.8K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2022-05-27) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics, Inc. | COM | 48576A100 | $369.3K | 2,912,872 | 52.8% |
| Eqrx, Inc. | COM | 26886C107 | $150.1K | 36,335,375 | 21.4% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $95.1K | 11,055,554 | 13.6% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $57.3K | 2,508,809 | 8.2% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $24.0K | 3,798,926 | 3.4% |
| Rubius Therapeutics, Inc. | COM | 78116T103 | $1.9K | 349,908 | 0.3% |
| Metacrine, Inc.A | COM | 59101E103 | $1.8K | 2,940,503 | 0.3% |
| Zymergen Inc. | COM | 98985X100 | $345 | 119,205 | 0.0% |